Comparison results
Results: Differences Similar | ✘Thrombocytopathy | ✘Hemorrhagic syndrome | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 26% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 89% | |||||||
paraproteinemia | 25% | — | |||||||
hemorrhagic syndrome | 16% | 100% | |||||||
bruises on the legs | 23% | — | |||||||
hematoma | — | 71% | |||||||
vitamin c increased | 22% | — | |||||||
hemarthrosis | — | 70% | |||||||
petechiae on the legs | 22% | — | |||||||
munchausen syndrome | — | 70% | |||||||
vitamin b12 boost2 | 21% | — | |||||||
nosebleeds in the afternoon | — | 67% | |||||||
vitamin c reduced | 20% | — | |||||||
intestinal bleeding | — | 65% | |||||||
scurvy | 19% | — | |||||||
willebrand 's disease | 21% | 84% | |||||||
parasitic liver diseases | 19% | — | |||||||
bleeding | 17% | 79% | |||||||
b12-deficiency anemia | 18% | — | |||||||
angiopathy | — | 60% | |||||||
poisoning addison | 17% | — | |||||||
dic syndrome | 15% | 75% | |||||||
spotting between periods | 17% | — | |||||||
hemorrhagic diathesis | 21% | 78% | |||||||
blood loss | 17% | — | |||||||
bruise | 14% | 71% | |||||||
rash on the nose | 17% | — | |||||||
vasculitis | — | 56% | |||||||
red rash on the legs | 17% | — | |||||||
retroperitoneal hematoma | — | 54% | |||||||
rash on the limbs | 16% | — | |||||||
ulcers in the nose | — | 54% | |||||||
bleeding uterine | 16% | — | |||||||
blue skin | 13% | 64% | |||||||
posthemorrhagic anemia | 16% | — | |||||||
red rash | 13% | 63% | |||||||
with anemia | 16% | — | |||||||
hemorrhagic vasculitis | — | 50% | |||||||
vitamin b12 reduction2 | 16% | — | |||||||
thrombocytopathy | 41% | 90% | |||||||
changes in the blood | 16% | — | |||||||
angiomatosis | — | 47% | |||||||
big nose | 16% | — | |||||||
systemic vasculitis | — | 46% | |||||||
worse at 12 o'clock | 15% | — | |||||||
petechiae | 15% | 60% | |||||||
hepatic cell carcinoma | 15% | — | |||||||
consequences of injuries | 11% | 56% | |||||||
uremia | 15% | — | |||||||
bleeding | 24% | 69% | |||||||
red legs | 15% | — | |||||||
red dots | 15% | 59% | |||||||
rash in the mouth | 15% | — | |||||||
pretending to be sick | — | 43% | |||||||
posttransfusion complications | 15% | — | |||||||
nosebleed in the morning | 24% | 67% | |||||||
cancer | 15% | — | |||||||
small-point rash | 14% | 56% | |||||||
mucous hyperemia | 14% | — | |||||||
hemorrhages on the skin | 14% | 55% | |||||||
leukemia | 14% | — | |||||||
the skin is black | 13% | 54% | |||||||
rashes on his legs | 14% | — | |||||||
injury | 10% | 50% | |||||||
serum sickness | 14% | — | |||||||
gastrointestinal bleeding | — | 40% | |||||||
oncology | 14% | — | |||||||
pus on the tonsils | — | 39% | |||||||
lymphocytic | 14% | — | |||||||
sore | — | 39% | |||||||
vitamin c deficiency | 13% | — | |||||||
arterial bleeding | — | 39% | |||||||
effects of puberty | 13% | — | |||||||
general tension | — | 38% | |||||||
protein reduced | 13% | — | |||||||
inflammation | — | 38% | |||||||
helminths | 13% | — | |||||||
reddening of the skin | — | 36% | |||||||
cirrhosis of the liver | 13% | — | |||||||
neurosis | — | 36% | |||||||
liver dysfunction | 13% | — | |||||||
blood diseases | 22% | 57% | |||||||
protein with increased | 12% | — | |||||||
gradual deterioration of | — | 34% | |||||||
protein c deficiency | 12% | — | |||||||
intestinal insufficiency syndrome | — | 34% | |||||||
benign neoplasms | 12% | — | |||||||
arthropathy | — | 33% | |||||||
female pelvic organs | 12% | — | |||||||
diseases of the gastrointestinal tract | — | 30% | |||||||
shortness | 12% | — | |||||||
consequences of infection | — | 29% | |||||||
kidney disease | 11% | — | |||||||
skin problems | — | 29% | |||||||
liver diseases | 11% | — | |||||||
blood dark | 16% | 45% | |||||||
hematuria | 11% | — | |||||||
family man | 12% | 35% | |||||||
blood paraproteins are lowered | 9% | — | |||||||
thrombocytopenia | 29% | 52% | |||||||
nosebleed | 22% | 45% |
Instructions
Video
|